Failure of filgrastim to prevent severe clozapine-induced agranulocytosis

Southern Medical Journal

Volumn 101, Issue 6, 2008, Pages 639-640

  Stewart, Jonathan T ^a,b   Majczenko, Tricia G ^c  

^a Bay Pines VA Medical Center   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

Agranulocytosis; Bipolar illness; Clozapine; Filgrastim; Neutropenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CIPROFLOXACIN; CLOZAPINE; LITHIUM CARBONATE; MOOD STABILIZER; NEUROLEPTIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VALPROIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR;

ADD ON THERAPY; ADULT; AGRANULOCYTOSIS; ARTICLE; BIPOLAR DISORDER; BODY WEIGHT; CASE REPORT; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEVER; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MANIA; NEUTROPENIA; NEUTROPHIL COUNT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG RESISTANCE; MIDDLE AGED; RECURRENT DISEASE; RETREATMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FILGRASTIM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; RECURRENCE; RETREATMENT;

EID: 45149110464     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318172f6c6     Document Type: Article

References (6)

1. Munro J, O'Sullivan D, Andrews C, et al. Active monitoring of 12,760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry 1999;175:576-580.
2. Sperner-Unterweger B, Czeipek I, Gaggl S, et al. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF): remission despite continuous treatment with clozapine. Br J Psychiatry 1998;172:82-84.
3. Hagg S, Rosenius S, Spigset O. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Int Clin Psychopharmacol 2003;18:173-174.
4. Conus P, Nanzer N, Baumann P. An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia. Br J Psychiatry 2001;179:180.
5. Rajagopal G, Graham JG, Haut FFA. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia. J Intellect Disabil Res 2007;51:82-85.
6. Dunk LR, Annan LJ, Andrews CD. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry 2006;188:255-263.